poor grade
Endovascular Coiling versus Surgical Clipping for Poor Grade Ruptured Intracranial Aneurysms: Postoperative Complications and Clinical Outcome in a Multicenter Poor Grade Aneurysm Study
6
Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial
6
Endovascular Management of Poor Grade Aneurysmal Subarachnoid Hemorrhage in the Geriatric Population
5
Case Report Cerebral hernia induced by intracerebral hematoma in patients with poor-grade ruptured intracranial aneurysm: emergent surgical treatment without angiography
8
Nutritional support and brain tissue glucose metabolism in poor grade SAH: a retrospective observational study
9
The critical care management of poor grade subarachnoid haemorrhage
19
A Multicenter prospective study of poor-grade aneurysmal subarachnoid hemorrhage (AMPAS): observational registry study
6
Treatment of Poor Grade Subarachnoid Hemorrhage Trial
5
Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage
7
Tuberculosis: Awareness among Students in a Saudi University
9
<p>The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma</p>
9
High nuclear expression of proteasome activator complex subunit 1 predicts poor survival in soft tissue leiomyosarcomas
7
Original Article Clinical value of CD133 and nestin in patients with glioma: a population-based study
14
Sexual dimorphism in glioma glycolysis underlies sex differences in survival
17
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
6
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
8
Study of risk factors for severe pneumonia among children between 2 months to 5 years of age
5
Social inequalities in depressive symptoms and physical functioning in the Whitehall II Study: Exploring a common cause explanation
8
Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub cellular localization
11
MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma
10